Home › Neoplasms by Histologic Type › New York › New York City
Neoplasms by Histologic Type clinical trials in New York City, NY
3 studies for Neoplasms by Histologic Type are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- NYU Grossman School of Medicine, New York
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College-NY Presbyterian Hospital, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Neoplasms by Histologic Type trials in other cities
- Boston, MA5 studies
- Atlanta, GA5 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- St. Louis, MO3 studies
- Dallas, TX3 studies
- San Francisco, CA3 studies
- Clifton, NJ3 studies
- Baldwin Park, CA3 studies
- Tampa, FL3 studies
- Nashville, TN3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.